Financial Daily from THE HINDU group of publications
Sunday, Feb 26, 2006


Investment World
Features
Stocks
Shipping
Archives
Google

Group Sites

Investment World - Stocks
Markets - Recommendation


Savita Chemicals: Buy

Alagappan Arunachalam

Investors can consider taking exposure in Savita Chemicals (Rs 365), which quotes at about 10 times its trailing 12-month earnings.

The company is likely to maintain healthy growth in its lubricants and transformer oil businesses for the next couple of years.

Double-digit growth in the automobile industry, driven by increasing disposable incomes and low-cost financing for vehicles, will trickle into the demand for lubes.

As investments flow into the power sector to bridge the demand-supply gap, there will be ample opportunities for Savita's transformer oil business.

Ahead of peers

Despite being a late entrant, Savita Chemicals has outpaced peers in the industry by maintaining a consistent growth in excess of 20 per cent-plus. Savita Chemicals has been ramping up the capacity of its transformer oil business, which has had robust growth of 30 per cent over the last three years.

Large order-book positions in the power equipment point to emerging growth opportunities for Savita's transformer oil business. Though there is significant potential for revenue growth, the company's earnings are tempered by volatility in the forex market and fluctuations in crude oil prices.

Though Savita Chemicals faces margin pressure with prices of crude oil hovering around $60 a barrel, it has been successful in passing on a part of the rise in input costs to the user industry. Buy the stock with a one/two-year perspective.

More Stories on : Stocks | Recommendation | Chemicals

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page



Stories in this Section
Investment Quiz


Unitech: Reject
Fitting A/c in Omni LPG will not be effective
New Fund Offers — The money spinners
Bracing for Budget effect
Reliance Infocomm: Value likely on listing
Franklin India Bluechip: Invest
HDFC Capital Builder: Invest
UTI Mastergrowth: Hold
Tata Equity Opportunities
UTI MF launches UTI Contra Fund
Too many new offers for comfort
IVRCL Infrastructures: Buy
Marico Industries: Buy
Rajesh Exports: Buy
Tata Tea: Buy
Savita Chemicals: Buy
Nifty may head south — Indicators suggest negative bias
Chart Focus
Index View
Reliance consolidates ahead of uptrend
Query corner
Outlook for large-cap stocks
`Innova'-ted for the customer
Wheels & Deals
Chinese checker
Downside averaging
Options guide
Indian companies need to spot game-changing ideas
Taking stock of interest
Visa Steel: Avoid
BhagwatiAutocast: Avoid
Getting inside the mind of the traders



The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | Business Line | Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |

Copyright © 2006, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line